Linagliptin, a DPP-4 inhibitor currently under clinical development for type 2 diabetes, produced “meaningful” reductions in blood sugar, according to results of a late-stage clinical study. The results of a 24-week, open-label arm of a phase-3 study of the investigational drug linagliptin combined with the generic drug metformin, were announced …

In the latest results, dapagliflozin improved control when glimepiride was added. Through 48 weeks, dapagliflozin plus glimepiride reduced HbA1c levels by 0.37% to 0.70% compared with placebo plus glimepiride. There were also sustained reductions in fasting plasma glucose and post-prandial glucose and small reductions in total body weight (1.3 to …

Two take-outs a week are enough to increase the risk of diabetes and heart disease, research shows. Young adults were more likely to have hidden health problems if they treated themselves to fast food on a twice-weekly basis, the study found. Additionally, women appear to be more susceptible to the …

Overweight kids have lower levels of vitamin D than their slimmer counterparts, regardless of season, sex, or race and ethnicity.…

Adhering to a strict, low-carbohydrate diet two days per week led to greater reductions in weight and insulin levels when compared with standard daily dieting.…

Patients’ activity in the sympathetic nervous system that controls the fight or flight response appears to predict how well they will do when trying to lose weight….

Performing short cycle sprints three times a week could be enough to prevent and possibly treat type 2 diabetes.…

A study by Buitrago-Lopez and colleagues found that daily chocolate consumption had a positive effect on cardiovascular risk factors.…

Both tight glycemic control and poor glycemic control are associated with worse outcomes in diabetes patients with chronic kidney disease.…

An accelerated decline in brain function is an important risk that needs to be examined further in relation to glycemic control in older people with long-standing diabetes.…